Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.
Published February 13, 2013 · Recall initiated: December 18, 2012
Summary
FDA records drug Class I recall D-155-2013, published February 13, 2013 and initiated December 18, 2012. Recalling firm: Matrixx Initiatives Inc; Status: Terminated; Reported quantity: 46,752 bottles; Lot: Lot # 2J23, Exp 09/15. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Matrixx Initiatives Inc
- Distributor
- Nationwide.
- Lot
- Lot # 2J23, Exp 09/15
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACarboplatin Injection, 450 mg/45 mL (10 mg/mL), 45 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, ForFebruary 13, 2013
- FDALeukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Bayer HealthCareFebruary 13, 2013
- FDACarboplatin Injection, 600 mg/60 mL (10 mg/mL), 60 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, ForFebruary 13, 2013
- FDAIsovue -370 (Iopamidol) Injection 76%, Prefilled 10 x 75 mL (NDC 0270-1316-66), 10 x 100 mL (NDCFebruary 13, 2013
- FDASyeda (drospirenone and ethinyl estradiol), 3 mg/0.03 mg, 3 x 28 tablet blistercards, combination oralFebruary 13, 2013
- FDAIsovue -300 (Iopamidol) Injection 61% Prefilled, 10 x 100 mL Power Injector Syringe, Rx Only, Manufactured forFebruary 13, 2013
Questions about this recall
Was Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0. recalled?
Yes. FDA published recall D-155-2013 on February 13, 2013. Reported hazard: Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release